PARP Inhibition in Ovarian Cancer: BRCA-Mutated and Beyond

home / precision-medicine / parp-ovarian-cancer

Ovarian Cancer

Understanding the Biological Targets of PARP Inhibitors

EP. 1: Understanding the Biological Targets of PARP Inhibitors

November 18th 2019

Watch

Current Landscape of PARP Inhibition in Ovarian Cancer

EP. 2: Current Landscape of PARP Inhibition in Ovarian Cancer

November 18th 2019

Watch

PARPi Maintenance in HRD+ Ovarian Cancer: The PRIMA Trial

EP. 3: PARPi Maintenance in HRD+ Ovarian Cancer: The PRIMA Trial

November 18th 2019

Watch

The VELIA Trial: PARPi + Chemo Preceding Maintenance Therapy

EP. 4: The VELIA Trial: PARPi + Chemo Preceding Maintenance Therapy

November 18th 2019

Watch

Antiangiogenic Therapy in Ovarian Cancer Management

EP. 5: Antiangiogenic Therapy in Ovarian Cancer Management

November 18th 2019

Watch

The PAOLA Trial: Layering PARPi Onto Antiangiogenic Therapy

EP. 6: The PAOLA Trial: Layering PARPi Onto Antiangiogenic Therapy

November 18th 2019

Watch

Practical Use of PARP Inhibitors in Ovarian Cancer

EP. 7: Practical Use of PARP Inhibitors in Ovarian Cancer

November 18th 2019

Watch

PARP Inhibition in Ovarian Cancer: What's Next?

EP. 8: PARP Inhibition in Ovarian Cancer: What's Next?

November 18th 2019

Watch